Antibacterial and antiviral high-performance nanosystems to mitigate new SARS-CoV-2 variants of concern
Review article
[키워드] Aerosols
Antibacterial
Antiviral
Biomarker
Coronavirus diseases 2019
COVID-19 infection
COVID-19 pandemic
COVID-19Coronavirus diseases 2019
Critical
diagnostics
droplets
Effectiveness
Effects
facilitate
FDAFood and Drug Administration
FETField-effect-transistor
Field-effect-transistor
filtration
Food and Drug Administration
functional
global healthcare
Health
immune response
Infection
Layer-by-Layer
LBLLayer-by-Layer
management
Masks
mitigate
Mutation
Nanosystem
Neutralizing
new SARS-CoV-2
NSNanosystem
pandemic
pathway
Protective
quarantine
respiratory fluid
SARS-CoV-2 propagation
SARS-CoV-2 variant
SARS-CoV-2severe acute respiratory syndrome coronavirus 2
selective
severe acute respiratory syndrome coronavirus 2
Severe infection
severity
the SARS-CoV-2
Transmission
Treatment
variant
variants of concern
virus
[DOI] 10.1016/j.cobme.2021.100363 [Article Type] Review article
[DOI] 10.1016/j.cobme.2021.100363 [Article Type] Review article